Jiangsu Hengrui Pharmaceuticals (01276) plans to repurchase 1 billion to 2 billion yuan of A-shares for the A-share employee stock ownership plan.
Hengrui Medicine (01276) announced that, based on confidence in the company's future development prospects and assessments of its fundamentals, in order to protect the interests of the company and the broad investor base, improve the long-term incentive mechanism for employees, and fully stimulate employee motivation, the company plans to use its own funds to buy back no less than 1 billion yuan and no more than 2 billion yuan of its A-shares, with a buyback price not exceeding 81.78 yuan per share. The shares repurchased will be used for the employee stock ownership plan for A-shares.
Jiangsu Hengrui Pharmaceuticals (01276) announced that based on confidence in the company's future development prospects and judgment of its fundamentals, to safeguard the interests of the company and the vast majority of investors, improve the long-term incentive mechanism for employees, and fully motivate employee enthusiasm, the company plans to use its own funds to repurchase not less than 1 billion yuan and not more than 2 billion yuan of its A-share stocks, with a repurchase price not exceeding 81.78 yuan per share. The repurchased shares will be used for the A-share employee stock ownership plan.
Related Articles
US Stock Market Move | Popular Chinese concept stocks rise broadly, with H World Group Limited Sponsored ADR (HTHT.US) up nearly 6%.
CAPITAL FIN (08239) issues a profit warning, expecting interim profit attributable to shareholders to increase by no less than approximately HKD 10 million compared to the same period last year.
GLOBAL BIO-CHEM (00809) appoints Xiao Zexian as Executive Director and Chairman of the Board.
US Stock Market Move | Popular Chinese concept stocks rise broadly, with H World Group Limited Sponsored ADR (HTHT.US) up nearly 6%.
CAPITAL FIN (08239) issues a profit warning, expecting interim profit attributable to shareholders to increase by no less than approximately HKD 10 million compared to the same period last year.
GLOBAL BIO-CHEM (00809) appoints Xiao Zexian as Executive Director and Chairman of the Board.
RECOMMEND
